Fosun Pharma: Net profit for the first half of 2025 was 318 million yuan, a year-on-year decrease of 6.35%.

Fosun Pharma announced that its operating income in the first half of 2025 was 649 million yuan, a year-on-year decrease of 11.55%; net profit was 318 million yuan, a year-on-year decrease of 6.35%. The profit distribution plan approved by the board of directors is based on 748 million shares, distributing a cash dividend of 3.6 yuan per 10 shares to all shareholders, with no bonus shares and no capitalization of reserves.